Literature DB >> 26363847

The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant.

Ji Lee1, Peace Imani2, Jessica Geer3, Michael Braun2, Poyyapakkam Srivaths2, Alvaro Orjuela2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26363847     DOI： 10.1053/j.ajkd.2015.07.028

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  2 in total

1.  Eculizumab Use in a Temporarily Dialysis-Dependent Patient With Shiga Toxin-Producing Escherichia Coli Hemolytic Uremic Syndrome With Neurological Complications.

Authors:  Bo Weber; Dominic Chan; Sandy Hammer
Journal:  J Pediatr Pharmacol Ther       Date:  2021-12-22

2.  Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report.

Authors:  Joseph L Alge; Scott E Wenderfer; John Hicks; Mir Reza Bekheirnia; Deborah A Schady; Jamey S Kain; Michael C Braun
Journal:  BMC Nephrol       Date:  2017-07-18       Impact factor: 2.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.